Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Modulation of Efferocytosis and Inflammation Resolution by Live and Non-Live Probiotics Through Gut Microbiota Interactions in Preclinical and Clinical Studies Publisher



Arianejad M1 ; Tajeddini F2 ; Zareardalan M3 ; Hosseinpoursoleimani F4, 5 ; Sisakht M6 ; Tajbakhsh A7 ; Pirsalehi MT7 ; Negahdaripour M7, 8
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Molecular Medicine, School of Advanced Technologies of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Biology, College of Sciences, Shiraz University, Shiraz, Iran
  3. 3. Department of Biotechnology and Cellular and Molecular Research Center, Faculty of Allied Medicine, Iran University of Medical Sciences, Tehran, 141761, Iran
  4. 4. Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran
  5. 5. Department of Applied Cell Sciences and Tissue Engineering, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran
  6. 6. Department of Molecular Medicine, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran
  7. 7. Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  8. 8. Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran

Source: Food Bioscience Published:2024


Abstract

Gut microbiota plays a critical role in maintaining health and is implicated in various diseases. Probiotics, prebiotics, synbiotics, and postbiotics (PPSPs) are potential therapeutic approaches for modifying the gut microbiota to prevent or treat associated disorders. This modulation influences apoptotic cell clearance (efferocytosis) and inflammation resolution. These processes are vital for immune function and tissue homeostasis. Evidence from animal and human studies indicates that PPSPs can enhance efferocytosis, leading to reduced inflammation and tissue damage. Additionally, PPSPs may ameliorate diseases such as metabolic syndrome, gastrointestinal disorders, and neurodegenerative conditions, by modulating gut microbiota composition and metabolite production. Notably, non-viable probiotics also enhance natural defense against infections, boost vaccine responses, and reduce common cold incidence. Clinical trials show promising outcomes for PPSPs in treating inflammatory bowel disease and certain cancers. However, further research is needed to determine the specific strains, dosages, and durations of PPSPs for optimizing their therapeutic efficacy. Overall, modulating gut microbiota through PPSPs represents a promising avenue for disease prevention and treatment, particularly in enhancing apoptotic cell clearance and attenuating inflammation and tissue damage. © 2024 Elsevier Ltd
Related Docs
View other Related Docs
1. The Regulation of Efferocytosis Signaling Pathways and Adipose Tissue Homeostasis in Physiological Conditions and Obesity: Current Understanding and Treatment Options, Obesity Reviews (2022)
2. Intestinal Microbiota: Novel Personalized Cancer Immunotherapy in Colorectal Cancer, International Archives of Allergy and Immunology (2022)
3. The Anti-Obesity Effects of Postbiotics: A Systematic Review of Pre-Clinical and Clinical Studies, Clinical Nutrition ESPEN (2024)
4. Gut Microbiome and Multiple Sclerosis: New Insights and Perspective, International Immunopharmacology (2020)
5. Role of Microbiota-Derived Short-Chain Fatty Acids in Nervous System Disorders, Biomedicine and Pharmacotherapy (2021)
6. Spondyloarthropathies and Gut Microbiota, Ankylosing Spondylitis - Axial Spondyloarthritis: Cellular# Molecular and Environmental Factors (2021)
7. Linking Diet and Gut Microbiota in Multiple Sclerosis, Diet and Nutrition in Neurological Disorders (2023)
8. The Emerging Microbiome-Based Approaches to Ibd Therapy: From Scfas to Urolithin A, Journal of Digestive Diseases (2022)
Experts (# of related papers)
View all Related Experts
Hanieh-Sadat Ejtahed (8)
Kurosh Djafarian (5)
Other Related Docs
9. Dual Role of Microbiota-Derived Short-Chain Fatty Acids on Host and Pathogen, Biomedicine and Pharmacotherapy (2022)
10. Probiotics Supplementation for the Obesity Management; a Systematic Review of Animal Studies and Clinical Trials, Journal of Functional Foods (2019)
11. Carcinogenic and Anticancer Activities of Microbiota-Derived Secondary Bile Acids, Frontiers in Oncology (2025)
12. Lifestyle Alters Gut-Bacteria Function: Linking Immune Response and Host, Best Practice and Research: Clinical Gastroenterology (2017)
13. Immunosuppressive Effects of Two Probiotics, Lactobacillus Paracasei Dsm 13434 and Lactobacillus Plantarum Dsm 15312, on Cd4+ T Cells of Multiple Sclerosis Patients, Iranian Journal of Allergy# Asthma and Immunology (2023)
14. The Interplay Between Gut Microbiota and Autism Spectrum Disorders: A Focus on Immunological Pathways, Progress in Neuro-Psychopharmacology and Biological Psychiatry (2021)
15. Probiotics for Prophylaxis and Management of Breast Cancer: Preclinical and Clinical Evidence, Probiotic Research in Therapeutics: Volume 1: Applications in Cancers and Immunological Diseases (2020)
16. Characterization of Gut Microbiota Profile in Iranian Patients With Bipolar Disorder Compared to Healthy Controls, Frontiers in Cellular and Infection Microbiology (2023)
17. Tryptophan Metabolites Modulate Inflammatory Bowel Disease and Colorectal Cancer by Affecting Immune System, International Reviews of Immunology (2022)
18. Gut Microbiota and Covid-19: A Systematic Review, Health Science Reports (2023)
19. Effect of Probiotic and Synbiotic Supplementation on Inflammatory Markers in Health and Disease Status: A Systematic Review and Meta-Analysis of Clinical Trials, Clinical Nutrition (2020)
20. Updates of Cancer Hallmarks in Patients With Inborn Errors of Immunity, Current Opinion in Allergy and Clinical Immunology (2022)
21. The Effect of Probiotics on Immune Responses and Their Therapeutic Application: A New Treatment Option for Multiple Sclerosis, Biomedicine and Pharmacotherapy (2023)
22. Comparative Efficacy and Safety of Probiotics, Prebiotics, and Synbiotics for Type 2 Diabetes Management: A Systematic Review and Network Meta-Analysis, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2024)
23. Beneficial Effects of Inactive and Non-Viable Probiotics on Health, Journal of Mazandaran University of Medical Sciences (2021)
24. Prophylactic Vs. Therapeutic Effect of Probiotics on the Inflammation Mediated by the Nf-Κb Pathway in Inflammatory Bowel Conditions, Biomedicines (2023)
25. Effect of Probiotic and Prebiotic Versus Placebo on Appetite in Patients With Major Depressive Disorder: Post Hoc Analysis of a Randomised Clinical Trial, Journal of Human Nutrition and Dietetics (2020)
26. Effect of Synbiotic Mouthwash on Oral Mucositis Induced by Radiotherapy in Oral Cancer Patients: A Double-Blind Randomized Clinical Trial, Supportive Care in Cancer (2023)
27. Effect of Probiotic and Prebiotic Vs Placebo on Psychological Outcomes in Patients With Major Depressive Disorder: A Randomized Clinical Trial, Clinical Nutrition (2019)
28. Epigenetic Alterations in Aging Tooth and the Reprogramming Potential, Ageing Research Reviews (2020)
29. Updated Perspectives on the Contribution of the Microbiome to the Pathogenesis of Mucositis Using the Mascc/Isoo Framework, Supportive Care in Cancer (2024)
30. The Immune System, Clinical Immunology (2022)
31. Bacterial Biofilm in Colorectal Cancer: What Is the Real Mechanism of Action?, Microbial Pathogenesis (2020)
32. Combined Use of Lactic-Acid-Producing Bacteria As Probiotics and Rotavirus Vaccine Candidates Expressing Virus-Specific Proteins, Archives of Virology (2021)
33. Non-Alcoholic Fatty Liver Diseases: From Role of Gut Microbiota to Microbial-Based Therapies, European Journal of Clinical Microbiology and Infectious Diseases (2020)
34. Microbes: Possible Link Between Modern Lifestyle Transition and the Rise of Metabolic Syndrome, Obesity Reviews (2019)
35. The Influence of Probiotics Consumption on Management of Prediabetic State: A Systematic Review of Clinical Trials, International Journal of Clinical Practice (2022)
36. Human Microbiome and Prostate Cancer Development: Current Insights Into the Prevention and Treatment, Frontiers of Medicine (2021)
37. The Effect of Probiotics on Gestational Diabetes and Its Complications in Pregnant Mother and Newborn: A Systematic Review and Meta-Analysis During 2010–2020, Journal of Clinical Laboratory Analysis (2022)
38. Interplay Between Gut Microbiota and the Master Iron Regulator, Hepcidin, in the Pathogenesis of Liver Fibrosis, Pathogens and Disease (2024)
39. Fermented Foods and Inflammation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials, Clinical Nutrition ESPEN (2020)
40. Microbiome Alterations in Women With Gestational Diabetes Mellitus and Their Offspring: A Systematic Review, Frontiers in Endocrinology (2022)
41. Interactions Between Probiotics and Pathogenic Microorganisms in Hosts and Foods: A Review, Trends in Food Science and Technology (2020)
42. A Critical Review on Akkermansia Muciniphila: Functional Mechanisms, Technological Challenges, and Safety Issues, Probiotics and Antimicrobial Proteins (2023)
43. Decreased Mucosal Adhesion of Lactobacillus Species in Patients With Inflammatory Bowel Disease, Caspian Journal of Internal Medicine (2022)
44. Gut Microbiota As a Target in the Pathogenesis of Metabolic Disorders: A New Approach to Novel Therapeutic Agents, Hormone and Metabolic Research (2016)
45. Celiac Disease: A Review From Genetic to Treatment, Iranian Biomedical Journal (2024)
46. Therapeutic Potential of Apoptotic Vesicles in Modulating Inflammation, Immune Responses, and Tissue Regeneration, Journal of Nanobiotechnology (2025)
47. Ginger Extract Improves Cognitive Dysfunction Via Modulation of Gut Microbiota-Derived Short-Chain Fatty Acids in D-Galactose/Ovariectomy-Induced Alzheimer-Like Disease, Molecular Neurobiology (2025)
48. Bacterial Biomarkers: New Aspects of Colorectal Tumors Diagnosis: Reality or Fantasy, European Journal of Cancer Prevention (2023)
49. Significant Difference in Gut Microbiota Bifidobacterium Species But Not Lactobacillus Species in Colorectal Cancer Patients in Comparison With Healthy Volunteers Using Quantitative Real-Time Pcr, PLoS ONE (2024)
50. Effect of Probiotic Supplementation on Cd4 Cell Count in Hiv-Infected Patients: A Systematic Review and Meta-Analysis, Journal of Dietary Supplements (2018)